Robspas M 80mg/250mg Tablet
Marketer
Park Pharmaceuticals
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Robspas M 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Robspas M 80mg/250mg tablets. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Administered with food, the dosage and duration of Robspas M 80mg/250mg tablets are determined by your physician, tailored to your individual needs and response. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common, generally transient side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, anorexia, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or activities demanding concentration until effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Disclose pregnancy, pregnancy plans, or breastfeeding, as well as any liver or kidney conditions, to your doctor for appropriate dosage adjustment.
Primary Ingredients of Robspas M 80mg/250mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Robspas M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Robspas M 80mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Robspas M 80mg/250mg Tablet with a meal.
Common Side effects of Robspas M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Robspas M 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Robspas M 80mg/250mg Tablets should be administered with food.
How Robspas M 80mg/250mg Tablet works:
Robspas M 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, easing contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain- and inflammation-inducing chemical mediators in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining Robspas M 80mg/250mg tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Use of Robspas M 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Robspas M 80mg/250mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Robspas M 80mg/250mg Tablets, a potential side effect of this medication due to the possibility of vertigo.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Robspas M 80mg/250mg tablets, as dosage modification may be necessary. Consult your physician for guidance. Robspas M 80mg/250mg tablets are contraindicated in individuals with severely compromised renal function.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Robspas M 80mg/250mg tablets. Dosage modification for Robspas M 80mg/250mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Robspas M 80mg/250mg Tablet :
Should you forget a Robspas M 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Robspas M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently